BioMarin Pharmaceutical Inc (BMRN) Sec Form 8K
BioMarin Pharmaceutical Inc (NASDAQ: BMRN) Sec Form 8K
22 articles, transcripts, and reports
BioMarin Pharmaceutical Inc (NASDAQ: BMRN) Sec Form 8K
BioMarin Pharmaceutical Inc (NASDAQ: BMRN) Summit Meeting
BioMarin Pharmaceutical Inc (NASDAQ: BMRN) FY 2026 Corporate Conference
BioMarin Pharmaceutical Inc (NASDAQ: BMRN) FY 2026 Corporate Conference
BioMarin Pharmaceutical Inc (NASDAQ: BMRN) FY 2026 Corporate Conference
BioMarin Pharmaceutical Inc (NASDAQ: BMRN) Q4 2025 Earnings Release
BioMarin Pharmaceutical Inc (NASDAQ: BMRN) Q4 2025 Earnings Conference
BioMarin Pharmaceutical Inc (NASDAQ: BMRN) Sec Form 8K
BioMarin Pharmaceutical Inc (NASDAQ: BMRN) FY 2026 Other Release
BioMarin Pharmaceutical Inc (NASDAQ: BMRN) Q2 2025 Earnings Call dated Aug. 04, 2025 Corporate Participants: Traci McCarty — Investor Relations Alexander Hardy — President and…